Display options
Share it on

J Cell Signal. 2021;2(1):9-26.

FOXP1 Interacts with MyoD to Repress its Transcription and Myoblast Conversion.

Journal of cellular signaling

Woodring E Wright, Chuan Li, Chang-Xue Zheng, Haley O Tucker

Affiliations

  1. Department of Cell Biology, UT Southwestern Medical School, Dallas TX 75235, USA.
  2. Department of Microbiology, University of Texas Southwestern Medical Center, Dallas TX 75235, USA.
  3. Department of Molecular Biosciences, the University of Texas at Austin, Austin TX 78712, USA.

PMID: 33554216 PMCID: PMC7861563

Abstract

Forkhead transcription factors (TFs) often dimerize outside their extensive family, whereas bHLH transcription factors typically dimerize with E12/E47. Based on structural similarities, we predicted that a member of the former, Forkhead Box P1 (FOXP1), might heterodimerize with a member of the latter, MYOD1 (MyoD). Data shown here support this hypothesis and further demonstrate the specificity of this forkhead/myogenic interaction among other myogenic regulatory factors. We found that FOXP1-MyoD heterodimerization compromises the ability of MyoD to bind to E-boxes and to transactivate E box- containing promoters. We observed that FOXP1 is required for the full ability of MyoD to convert fibroblasts into myotubules. We provide a model in which FOXP1 displaces ID and E12/E47 to repress MyoD during the proliferative phase of myoblast differentiation. These data identify FOXP1 as a hitherto unsuspected transcriptional repressor of MyoD. We suggest that isolation of paired E-box and forkhead sites within 1 turn helical spacings provides potential for cooperative interactions among heretofore distinct classes of transcription factors.

Keywords: Forkhead box P1; Myoblast differentiation; Myogenic regulatory factors; Transcriptional regulation

Conflict of interest statement

Competing Financial Interests The authors declare no competing financial interests.

References

  1. Methods Enzymol. 2016;568:427-59 - PubMed
  2. Genes Dev. 2008 Mar 15;22(6):740-5 - PubMed
  3. Genes Dev. 1991 Aug;5(8):1377-86 - PubMed
  4. Genes Dev. 2019 Jun 1;33(11-12):626-640 - PubMed
  5. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5623-7 - PubMed
  6. Cell. 1991 Jul 26;66(2):305-15 - PubMed
  7. EMBO J. 2001 Apr 2;20(7):1739-53 - PubMed
  8. Development. 2005 Jun;132(12):2685-95 - PubMed
  9. Genes Dev. 2012 Dec 15;26(24):2763-79 - PubMed
  10. EMBO J. 1995 Apr 18;14(8):1766-72 - PubMed
  11. J Mol Biol. 1999 Sep 24;292(3):641-51 - PubMed
  12. J Muscle Res Cell Motil. 2019 Jun;40(2):211-226 - PubMed
  13. Cell. 1995 Dec 15;83(6):1011-20 - PubMed
  14. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6221-5 - PubMed
  15. Cell. 2006 Jul 28;126(2):375-87 - PubMed
  16. Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):5830-5837 - PubMed
  17. Expert Opin Ther Targets. 2007 Jul;11(7):955-65 - PubMed
  18. Sci Rep. 2017 Jun 6;7(1):2838 - PubMed
  19. Immunity. 2011 Apr 22;34(4):479-91 - PubMed
  20. Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):552-7 - PubMed
  21. Mol Cell Biol. 2004 Jan;24(2):809-22 - PubMed
  22. J Biol Chem. 2001 Jul 20;276(29):27488-97 - PubMed
  23. Cell. 2011 Oct 28;147(3):577-89 - PubMed
  24. Mol Ther. 2008 May;16(5):832-5 - PubMed
  25. Mol Cell Biol. 1989 Nov;9(11):5022-33 - PubMed
  26. Curr Opin Genet Dev. 2005 Oct;15(5):528-35 - PubMed
  27. Mol Cell Biol. 1999 Nov;19(11):7621-9 - PubMed
  28. Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 - PubMed
  29. Cold Spring Harb Perspect Biol. 2016 Oct 3;8(10): - PubMed
  30. Cell Rep. 2020 Mar 3;30(9):3051-3066.e7 - PubMed
  31. Mol Cell Biol. 1987 Feb;7(2):725-37 - PubMed
  32. Semin Cell Dev Biol. 2017 Dec;72:19-32 - PubMed
  33. Nat Commun. 2017 Dec 12;8(1):2070 - PubMed
  34. Clin Dev Immunol. 2007;2007:89017 - PubMed
  35. Nat Immunol. 2019 Feb;20(2):232-242 - PubMed
  36. Mol Psychiatry. 2015 May;20(5):632-9 - PubMed
  37. Sci Rep. 2018 Nov 1;8(1):16161 - PubMed
  38. Cancer Res. 2012 Jan 15;72(2):387-94 - PubMed
  39. Cell. 2011 Oct 28;147(3):565-76 - PubMed
  40. Biochim Biophys Acta. 1989 Jul 28;989(1):25-48 - PubMed
  41. Gene Expr Patterns. 2016 Mar;20(2):111-9 - PubMed
  42. Cell Cycle. 2016;15(2):196-212 - PubMed
  43. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11583-7 - PubMed
  44. Mini Rev Med Chem. 2006 Jul;6(7):765-70 - PubMed
  45. Mol Cancer. 2019 Dec 9;18(1):180 - PubMed
  46. Sci Rep. 2019 Apr 1;9(1):5441 - PubMed
  47. Nature. 1991 Aug 22;352(6337):689-95 - PubMed
  48. Science. 2004 Sep 10;305(5690):1619-22 - PubMed
  49. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10004-8 - PubMed
  50. Mol Cancer. 2019 Jan 8;18(1):5 - PubMed
  51. Nature. 1993 Jul 29;364(6436):412-20 - PubMed
  52. Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613 - PubMed
  53. Development. 2004 Sep;131(18):4477-87 - PubMed
  54. Blood. 2010 Jan 21;115(3):510-8 - PubMed
  55. J Biol Chem. 2003 Jul 4;278(27):24259-68 - PubMed
  56. Nature. 1991 Dec 5;354(6352):369-73 - PubMed
  57. Mol Ther. 2000 Jul;2(1):16-25 - PubMed
  58. Cell. 1992 Feb 7;68(3):507-19 - PubMed
  59. Int J Dev Biol. 2009;53(1):149-57 - PubMed
  60. Dev Cell. 2008 Oct;15(4):534-46 - PubMed
  61. Development. 2007 May;134(10):1991-2000 - PubMed
  62. Cardiovasc Res. 2013 Oct 1;100(1):105-13 - PubMed
  63. Front Immunol. 2020 Mar 10;11:195 - PubMed
  64. J Biol Chem. 1987 Mar 5;262(7):3322-30 - PubMed
  65. Nat Immunol. 2011 Jun;12(6):544-50 - PubMed
  66. Annu Rev Cell Dev Biol. 1998;14:167-96 - PubMed
  67. Nature. 1998 Mar 5;392(6671):42-8 - PubMed
  68. Mol Cancer. 2007 Mar 26;6:23 - PubMed
  69. Stem Cells Transl Med. 2014 Feb;3(2):183-93 - PubMed
  70. Skelet Muscle. 2011 Jul 07;1:25 - PubMed
  71. Dev Cell. 2016 Feb 22;36(4):375-85 - PubMed
  72. Hum Mol Genet. 2018 Apr 1;27(7):1212-1227 - PubMed

Publication Types

Grant support